CN106421673A - 一种治疗hpv病毒感染的中药组合物及其制备方法 - Google Patents
一种治疗hpv病毒感染的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN106421673A CN106421673A CN201611146425.9A CN201611146425A CN106421673A CN 106421673 A CN106421673 A CN 106421673A CN 201611146425 A CN201611146425 A CN 201611146425A CN 106421673 A CN106421673 A CN 106421673A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- herba
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 241000701806 Human papillomavirus Species 0.000 title abstract description 5
- 208000015181 infectious disease Diseases 0.000 title abstract description 5
- 210000002826 placenta Anatomy 0.000 claims abstract description 11
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 10
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 19
- 230000009385 viral infection Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- -1 tragakanta Polymers 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000009806 pulsatillae Substances 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000000344 soap Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000004411 aluminium Substances 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- 239000010685 fatty oil Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 241001635598 Enicostema Species 0.000 claims 1
- 244000296102 Selinum monnieri Species 0.000 claims 1
- 235000019084 Selinum monnieri Nutrition 0.000 claims 1
- 235000020985 whole grains Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 7
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract description 5
- 208000037976 chronic inflammation Diseases 0.000 abstract description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 abstract 2
- 239000010436 fluorite Substances 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000206469 Pulsatilla Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 241000722921 Tulipa gesneriana Species 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 244000178320 Vaccaria pyramidata Species 0.000 description 2
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229960002566 papillomavirus vaccine Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004394 topiramate Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及中医药制备技术领域,具体地说是一种治疗HPV病毒感染的中药组合物及其制备方法,由下述原料制成:紫草、紫花地丁、紫石英、紫河车、蛇床子、生黄芪、天花粉、人参、当归、紫石英、紫草、地丁、蛇床子、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷、麦芽。本发明同现有技术相比,具有祛湿的作用,即调节体内脂质代谢紊乱和缓解免疫系统黏膜发生的慢性炎症的作用。本发明的中药组合物可以治疗HPV病毒感染,具有显著的效果,副作用小,可长期服用;并且中药组合物服用量小,服用方便,并且能较好的保证药物稳定性和效果。
Description
技术领域
本发明涉及中医药制备技术领域,具体地说是一种治疗HPV病毒感染的中药组合物及其制备方法。
背景技术
宫颈癌是最常见的女性生殖系统恶性肿瘤。在发展中国家,是女性癌症死亡率第1位因素。在发达国家,近几年死亡率也有回升的趋势。大量流行病学和分子生物学研究资料表明, 人乳头瘤病毒 HPV与子宫颈癌及癌前病变密切相关。因此在HPV疫苗尚未广泛应用于临床之前,积极防治感染HPV感染对预防及降低宫颈癌的发生具有极其重要的意义。
目前西医治疗感染HPV最有效的方法T细胞介入加免疫激活疗法,但价格十分昂贵;而中医药治疗无论在改善临床症状,还是在长期疗效方面都有明显的优势。
因此,需要设计一种普遍有效的、毒副作用小的治疗HPV感染的中药组合物及其制备方法。
发明内容
本发明的目的是克服现有技术的不足,提供了一种普遍有效的、毒副作用小的治疗HPV感染的中药组合物及其制备方法。
为了达到上述目的,本发明是一种治疗HPV病毒感染的中药组合物,其特征在于:由下述重量份数的原料制成:紫草一30-35份、紫花地丁30-35份、紫石英一15-18份、紫河车5-8份、蛇床子一5-10份、莪术13-17份、生黄芪25-30 份、天花粉8-14份、人参1-3份、当归8-12份、紫石英二12-15份、紫草二12-15份、地丁12-15份、蛇床子二12-15份、地肤子10-13份、牛蒡子10-13份、白蒺藜9-14份、乌蛇8-12份、炙麻黄7-10份、白芥子10-14份、红藤10-15份、鱼腥草10-15份、蒲公英8-12份、山慈菇12-14份、白头翁8-12份、土茯苓9-12份、鬼针草8-12份、元胡12-14份、炒谷8-12份、麦芽12-14份。
所述的紫草、紫花地丁、紫石英、紫河车、蛇床子、生黄芪、天花粉、人参、当归、紫石英、紫草、地丁、蛇床子、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷、麦芽分别为各自的水提取物。
一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:按如下步骤制备:步骤1,称取所述重量份数的紫草一、紫花地丁、紫石英一、紫河车和蛇床子一,加水浸泡0.5~ 1 小时后,加热回流2 ~ 3 次,每次1 ~ 3 小时,收集挥发油并加入微晶纤维素混合均匀,形成挥发油赋形粉末,药液趁热过滤后,滤液合并,形成滤液一。
步骤2,称取所述重量份数的生黄芪、天花粉、人参、当归、紫石英二、紫草而、地丁、蛇床子二、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷和麦芽,加水煎煮2 次,第一次0.5 ~ 2 小时,第二次 1 ~ 3 小时,合并煎液,滤过,形成滤液二。
步骤3,合并滤液一和滤液二,以有机溶剂过滤浓缩后,回收有机溶剂,浓缩成稠膏,减压干燥并粉碎后,加入挥发油赋形粉末及辅料,混合均匀并制成颗粒后,依次进行干燥、整粒和包装,形成中药组合物制剂。
所述的步骤3中,有机溶剂为乙醇。
所述的步骤3中,以有机溶剂过滤浓缩的条件为浓缩至相对密度为 1.08 ~1.28,加入乙醇使含醇量为 50 ~ 70%。
所述的辅料为甘露醇。
所述的中药组合物制剂中添加稀释剂、润滑剂、粘合剂、崩解剂、甜味剂、稳定剂、防腐剂等中的一种或一种以上的混合物。
所述的中药组合物制剂为颗粒剂或凝胶剂。
所述的凝胶剂将合并滤液浓缩至原液体积的1/3后,增加赋形剂。
所述的赋形剂为水、甘油、丙二醇与纤维素衍生物、卡波姆和海藻酸盐、西黄蓍胶、明胶、淀粉、由液状石蜡与聚乙烯或脂肪油与胶体硅或铝皂、锌皂构成。
本发明同现有技术相比,具有祛湿的作用,即调节体内脂质代谢紊乱和缓解免疫系统黏膜发生的慢性炎症的作用。本发明的中药组合物可以治疗HPV病毒感染,具有显著的效果,副作用小,可长期服用;并且中药组合物服用量小,服用方便,并且能较好的保证药物稳定性和效果。其生产工艺简单、生产成本低、实施性强,易于大规模工业化生产。
具体实施方式
现结对本发明做进一步描述。
本发明是一种治疗HPV病毒感染的中药组合物,其特征在于:由下述重量份数的原料制成:紫草一30-35份、紫花地丁30-35份、紫石英一15-18份、紫河车5-8份、蛇床子一5-10份、莪术13-17份、生黄芪25-30 份、天花粉8-14份、人参1-3份、当归8-12份、紫石英二12-15份、紫草二12-15份、地丁12-15份、蛇床子二12-15份、地肤子10-13 份、牛蒡子10-13份、白蒺藜9-14份、乌蛇8-12份、炙麻黄7-10份、白芥子10-14份、红藤10-15份、鱼腥草10-15份、蒲公英8-12份、山慈菇12-14份、白头翁8-12份、土茯苓9-12份、鬼针草8-12份、元胡12-14份、炒谷8-12份、麦芽12-14份。
紫草、紫花地丁、紫石英、紫河车、蛇床子、生黄芪、天花粉、人参、当归、紫石英、紫草、地丁、蛇床子、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷、麦芽分别为各自的水提取物。
如本领域技术人员所知,在药物中实际起作用的是这些成分所含有的化学成分,因此所述的上述的各原料还可以是这些成分的提取物,包括水提取物和/或有机溶剂提取物,考虑到用药安全和制备方便的需要,优选的是其水提取物。
本发明的中药组合物既可以单独使用,为了服用方便,改善药物的风味和口感,优选的是药物制剂,包括本发明的中药组合物和药学上可接受的载体制备而成。然而,需要注意的是,本发明也可以将中药组合物单独使用,例如采用下述方法将中药组合物制成生药以供使用。
按照所述的重量份数,将各原料采用适当的水或者有机溶剂进行提取,优选的是用水进行提取,然后将各原料提取物混合干燥后粉碎混合均匀即可。
如上所述,在本发明中,所述的中药组合物通常是制备成药物制剂,其中所述的药学上可接受的载体是用于制备药物制剂常用的辅料成分,包括但不限于稀释剂、润滑剂、粘合剂、崩解剂、甜味剂、稳定剂、防腐剂等中的一种或一种以上的混合物,针对不同的制剂类型,选择不同的载体作为辅料对于本领域技术人员而言是显而易见的。
其中,上述的载体,其用量和用法、种类已在药学上充分公开。例如所述的稀释剂包括但不限于乳糖、淀粉、微晶纤维素、甘露醇等;所述的润滑剂包括但不限于硬脂酸镁、滑石粉等;所述的粘合剂包括但不限于聚乙烯吡洛烷酮、羟丙基纤维素等;所述的崩解剂包括但不限于羧甲基纤维素、乙酸羧基淀粉钠、交联聚维酮等;所述的甜味剂包括但不限于蔗糖、果糖、山梨糖醇等;所述的稳定剂包括但不限于羧甲基纤维素钠、环糊精、黄原胶等;所述的防腐剂包括但不限于山梨酸钾、尼泊金酯等。
本发明按如下步骤制备:步骤1,称取所述重量份数的紫草一、紫花地丁、紫石英一、紫河车和蛇床子一,加水浸泡0.5 ~ 1 小时后,加热回流2 ~ 3 次,每次1 ~ 3 小时,收集挥发油并加入微晶纤维素混合均匀,形成挥发油赋形粉末,药液趁热过滤后,滤液合并,形成滤液一。
步骤2,称取所述重量份数的生黄芪、天花粉、人参、当归、紫石英二、紫草而、地丁、蛇床子二、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷和麦芽,加水煎煮2 次,第一次0.5 ~ 2 小时,第二次 1 ~ 3 小时,合并煎液,滤过,形成滤液二。
步骤3,合并滤液一和滤液二,以有机溶剂过滤浓缩后,回收有机溶剂,浓缩成稠膏,减压干燥并粉碎后,加入挥发油赋形粉末及辅料,辅料为甘露醇,混合均匀并制成颗粒后,依次进行干燥、整粒和包装,形成中药组合物制剂。中药组合物制剂中添加稀释剂、润滑剂、粘合剂、崩解剂、甜味剂、稳定剂、防腐剂等中的一种或一种以上的混合物。
其中,所用的浓缩方法和干燥方法为本领域任意可用的方法,例如采用真空浓缩或常温减压浓缩,例如采用喷雾干燥或者冷冻干燥。
其中,将滤液与残渣分离的方法可以是本领域任意可用的方法,例如过滤或者离心的方法。
其中,有机溶剂为乙醇。以有机溶剂过滤浓缩的条件为浓缩至相对密度为 1.08~ 1.28,加入乙醇使含醇量为 50 ~ 70%。
中药组合物制剂为颗粒剂或凝胶剂。
采用上述方法及其制备条件,最有效的保证了提取的效果和产品的稳定性,并使得生产工艺简单,降低了生产成本。
进一步的,上述药物组合可以制备成适用于女性生殖道感染用凝胶剂,在上述制备颗粒剂的基础方法上进行制备药物提取物,凝胶剂将合并滤液浓缩至原液体积的1/3后,增加赋形剂。将提取液体积浓缩至原液的1/3,再加入赋形剂进行制备,包装。
赋形剂为水、甘油或丙二醇与纤维素衍生物、卡波姆和海藻酸盐、西黄蓍胶、明胶、淀粉;或由液状石蜡与聚乙烯或脂肪油与胶体硅或铝皂、锌皂构成,优选为甘油。
本发明的用法用量为:开水冲服,一次10~20克(1~3袋),每日1~3次,疗程1~3个月。根据不同病例的实际情况,可以进行相应的调整。
临床试验表明,本发明具有温肾活血,清热解毒的功效。用于防治HPV感染具有显著的治疗效果。
本发明所选用药物的药性及药理分别为:
紫草,性味归经:甘、咸,寒。归心、肝经。功能主治:凉血,活血,解毒透疹。用于血热毒盛,斑疹紫黑,麻疹不透,疮疡,湿疹,水火烫伤。
紫花地丁,性味归经:苦、辛,寒。归心、肝经。功能主治:清热解毒,凉血消肿。用于疔疮肿毒,痈疽发背,丹毒,毒蛇咬伤。
紫石英,性味归经:甘,温。归心、肺、肾经。功能主治:镇心安神,温肺,暖宫。用于失眠多梦,心悸易惊,肺虚咳喘,宫寒不孕。
紫河车,性味归经:甘、咸,温。归心、肺、肾经。功能主治:温肾补精,益气养血。用于虚劳羸瘦,骨蒸盗汗,咳嗽气喘,食少气短,阳痿遗精,不孕少乳。
蛇床子,性味归经:辛、苦,温;有小毒。归肾经。功能主治:温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;滴虫性阴道炎。
莪术,性味归经:辛、苦,温。归肝、脾经。功能主治:行气破血,消积止痛。用于燀瘕痞块,瘀血经闭,食积胀痛;早期宫颈癌。
治疗典型病例一:
患者,女,36岁,已婚。主诉:下身瘙痒,排卵期时肚子有点疼。咽喉难受,鼻子有点堵。清晨偶现肚子痛,腹泻1-2次。诊断:HPV检测呈阳性。治疗:服用本发明药物14天后,症状消失。
治疗典型病例二:
患者,女,43岁,已婚。主诉:下身瘙痒,外阴发现肿块增大伴疼痛、恶臭。诊断:外阴湿疣。治疗:使用本发明凝胶剂,一周后,恶臭消失,一月后,瘙痒减轻。
选54 例患者,随机分为治疗组与对照组,治疗组30例;年龄14岁-76岁,中位51岁;病程3个月-14个月,中位6个月。对照组24例;年龄16岁-67岁,中位48岁;病程1个月-12个月,中位5个月。2组性别、年龄及两治疗组病程差异均无统计学意义(P>0.05)。
治疗组给予抗本发明所制凝胶剂,每周3次,临睡前用药。对照组予5% 咪喹莫特,用药剂量为每周3次(星期一、三、五或二、四、六),临睡前用药,直至完成观察周期。三个月为一疗程,一般治疗2个疗程。
运用SPSS14.0统计软件,各组问均数比较采用单因素方差分析,组间两两比较采样、检验。P<0.05 为差异有显著性。
组别 | n | 治愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 30 | 14(46.7) | 10(33.3) | 4(13.3) | 2(6.7) | 28(93.3) |
对照组 | 24 | 8(33.3) | 6(25.0) | 7(29.2) | 3(12.5) | 21(87.5) |
上表中,治愈 :症状、体征消失,功能活动恢复正常,检查各项指标恢复。 显效 :症状明显减轻。 有效 :症状稍稍减轻。无效 :临床症状、体征无改变。
上表为治疗组和对照组总体疗效比较,采用本发明药物组合能够提高对 HPV 病毒感染的总体治疗效果,并且无毒副作用,治疗组与对照组相比,P<0.05,具有可比性。
Claims (10)
1.一种治疗HPV病毒感染的中药组合物,其特征在于:由下述重量份数的原料制成:紫草一30-35份、紫花地丁30-35份、紫石英一15-18份、紫河车5-8份、蛇床子一5-10份、莪术13-17份、生黄芪25-30 份、天花粉8-14份、人参1-3份、当归8-12份、紫石英二12-15份、紫草二12-15份、地丁12-15份、蛇床子二12-15份、地肤子10-13 份、牛蒡子10-13份、白蒺藜9-14份、乌蛇8-12份、炙麻黄7-10份、白芥子10-14份、红藤10-15份、鱼腥草10-15份、蒲公英8-12份、山慈菇12-14份、白头翁8-12份、土茯苓9-12份、鬼针草8-12份、元胡12-14份、炒谷8-12份、麦芽12-14份。
2.根据权利要求1所述的一种治疗HPV病毒感染的中药组合物,其特征在于:所述的紫草、紫花地丁、紫石英、紫河车、蛇床子、生黄芪、天花粉、人参、当归、紫石英、紫草、地丁、蛇床子、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷、麦芽分别为各自的水提取物。
3.一种如权利要求1所述的治疗HPV病毒感染的中药组合物的制备方法,其特征在于:按如下步骤制备:步骤1,称取所述重量份数的紫草一、紫花地丁、紫石英一、紫河车和蛇床子一,加水浸泡0.5 ~ 1 小时后,加热回流2 ~ 3 次,每次1 ~ 3 小时,收集挥发油并加入微晶纤维素混合均匀,形成挥发油赋形粉末,药液趁热过滤后,滤液合并,形成滤液一;步骤2,称取所述重量份数的生黄芪、天花粉、人参、当归、紫石英二、紫草而、地丁、蛇床子二、地肤子、牛蒡子、白蒺藜、乌蛇、炙麻黄、白芥子、红藤、鱼腥草、蒲公英、山慈菇、莪术、白头翁、土茯苓、鬼针草、元胡、炒谷和麦芽,加水煎煮2 次,第一次0.5 ~ 2 小时,第二次 1~ 3 小时,合并煎液,滤过,形成滤液二;
步骤3,合并滤液一和滤液二,以有机溶剂过滤浓缩后,回收有机溶剂,浓缩成稠膏,减压干燥并粉碎后,加入挥发油赋形粉末及辅料,混合均匀并制成颗粒后,依次进行干燥、整粒和包装,形成中药组合物制剂。
4.根据权利要求3所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的步骤3中,有机溶剂为乙醇。
5.根据权利要求3所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的步骤3中,以有机溶剂过滤浓缩的条件为浓缩至相对密度为 1.08 ~ 1.28,加入乙醇使含醇量为 50 ~ 70%。
6.根据权利要求3所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的辅料为甘露醇。
7.根据权利要求3所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的中药组合物制剂中添加稀释剂、润滑剂、粘合剂、崩解剂、甜味剂、稳定剂、防腐剂等中的一种或一种以上的混合物。
8.根据权利要求3所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的中药组合物制剂为颗粒剂或凝胶剂。
9.根据权利要求8所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的凝胶剂将合并滤液浓缩至原液体积的1/3后,增加赋形剂。
10.根据权利要求8所述的一种治疗HPV病毒感染的中药组合物的制备方法,其特征在于:所述的赋形剂为水、甘油、丙二醇与纤维素衍生物、卡波姆和海藻酸盐、西黄蓍胶、明胶、淀粉、由液状石蜡与聚乙烯或脂肪油与胶体硅或铝皂、锌皂构成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611146425.9A CN106421673B (zh) | 2016-12-13 | 2016-12-13 | 一种治疗hpv病毒感染的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611146425.9A CN106421673B (zh) | 2016-12-13 | 2016-12-13 | 一种治疗hpv病毒感染的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106421673A true CN106421673A (zh) | 2017-02-22 |
CN106421673B CN106421673B (zh) | 2020-01-24 |
Family
ID=58217057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611146425.9A Active CN106421673B (zh) | 2016-12-13 | 2016-12-13 | 一种治疗hpv病毒感染的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106421673B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107375553A (zh) * | 2017-08-10 | 2017-11-24 | 熊润之 | 一种防治hpv病毒感染的乳清茶配方及其制备方法 |
CN107551174A (zh) * | 2017-08-08 | 2018-01-09 | 湖北中医药大学 | 一种治疗宫颈hpv感染的外用中药及其制备方法 |
CN110327445A (zh) * | 2019-08-12 | 2019-10-15 | 贵州苗仁堂制药有限责任公司 | 一种抗hpv病毒、抗宫颈肿瘤苗药复方制剂 |
CN114470123A (zh) * | 2022-02-28 | 2022-05-13 | 湖南有美生物科技有限公司 | 一种用于治疗hpv病毒感染的医用妇科凝胶及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773636A (zh) * | 2009-01-09 | 2010-07-14 | 苏州知微堂生物科技有限公司 | 一种抗肿瘤纳米中药及其生产方法 |
CN102872246A (zh) * | 2012-10-19 | 2013-01-16 | 吴潮新 | 使人乳头状瘤病毒阳转阴治疗宫颈糜烂的药物及制备方法 |
CN103041283A (zh) * | 2011-10-12 | 2013-04-17 | 薛晓鸥 | 一种外用治疗宫颈hpv感染的中药组合物及其制备方法 |
CN103800684A (zh) * | 2014-03-05 | 2014-05-21 | 林仁耳 | 一种中西药同步外用治疗宫颈人乳头病毒(hpv)、上皮内瘤变(cin)及宫颈糜烂的根治术 |
CN104379170A (zh) * | 2012-06-20 | 2015-02-25 | 国立大学法人东京大学 | 粘膜免疫刺激剂及hpv感染症治疗用经口药物组合物 |
CN105582465A (zh) * | 2015-12-31 | 2016-05-18 | 蒲敬北 | 一种修复宫颈糜烂的中药复方制剂及其制作方法 |
CN105963392A (zh) * | 2016-07-04 | 2016-09-28 | 上海世道健康科技有限公司 | 一种中药组合物、制剂及其制备方法和用途 |
-
2016
- 2016-12-13 CN CN201611146425.9A patent/CN106421673B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773636A (zh) * | 2009-01-09 | 2010-07-14 | 苏州知微堂生物科技有限公司 | 一种抗肿瘤纳米中药及其生产方法 |
CN103041283A (zh) * | 2011-10-12 | 2013-04-17 | 薛晓鸥 | 一种外用治疗宫颈hpv感染的中药组合物及其制备方法 |
CN104379170A (zh) * | 2012-06-20 | 2015-02-25 | 国立大学法人东京大学 | 粘膜免疫刺激剂及hpv感染症治疗用经口药物组合物 |
CN102872246A (zh) * | 2012-10-19 | 2013-01-16 | 吴潮新 | 使人乳头状瘤病毒阳转阴治疗宫颈糜烂的药物及制备方法 |
CN103800684A (zh) * | 2014-03-05 | 2014-05-21 | 林仁耳 | 一种中西药同步外用治疗宫颈人乳头病毒(hpv)、上皮内瘤变(cin)及宫颈糜烂的根治术 |
CN105582465A (zh) * | 2015-12-31 | 2016-05-18 | 蒲敬北 | 一种修复宫颈糜烂的中药复方制剂及其制作方法 |
CN105963392A (zh) * | 2016-07-04 | 2016-09-28 | 上海世道健康科技有限公司 | 一种中药组合物、制剂及其制备方法和用途 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107551174A (zh) * | 2017-08-08 | 2018-01-09 | 湖北中医药大学 | 一种治疗宫颈hpv感染的外用中药及其制备方法 |
CN107375553A (zh) * | 2017-08-10 | 2017-11-24 | 熊润之 | 一种防治hpv病毒感染的乳清茶配方及其制备方法 |
CN110327445A (zh) * | 2019-08-12 | 2019-10-15 | 贵州苗仁堂制药有限责任公司 | 一种抗hpv病毒、抗宫颈肿瘤苗药复方制剂 |
CN114470123A (zh) * | 2022-02-28 | 2022-05-13 | 湖南有美生物科技有限公司 | 一种用于治疗hpv病毒感染的医用妇科凝胶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106421673B (zh) | 2020-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN106421673A (zh) | 一种治疗hpv病毒感染的中药组合物及其制备方法 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
US20210008145A1 (en) | Edicine composition for treatment of human papillomavirus infection and preparation method thereof | |
CN103463297A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法和用途 | |
CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN104922426A (zh) | 一种治疗妇产科术后低热症的药物组合物 | |
CN104383317A (zh) | 一种治疗肝癌的中药组合物 | |
CN115282229B (zh) | 一种治疗气虚血淤型冠心病的中药组合物及其制备方法 | |
CN104758900A (zh) | 一种用于治疗急性胰腺炎的中药 | |
CN105770691A (zh) | 一种用于治疗宫颈癌的药物制剂及其用途 | |
CN106334171A (zh) | 一种用于修复肝损伤的中药制剂及制备方法 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN103432466A (zh) | 治疗女性盆腔炎的中药组合物及其制备方法 | |
CN114949108B (zh) | 一种治疗前列腺炎的中药组合物及制备方法和应用 | |
CN109718283B (zh) | 一种平喘化痰中药组合物及其制备方法 | |
CN108653460B (zh) | 一种治疗慢性荨麻疹的中药组合物及其制备方法 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN101468124A (zh) | 一种防治月经不调的中药组合物及其制备方法 | |
CN102018849A (zh) | 一种防治月经不调的中药组合物及其制备方法 | |
CN105687644A (zh) | 一种治疗胃癌的中药组合物 | |
CN105597004A (zh) | 一种治疗癌症的中药组合物 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN104524149A (zh) | 一种防治急性肾炎的药物组合物及其应用 | |
CN104189400B (zh) | 一种治疗癌症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210917 Address after: 200135 building C, No. 888, Huanhu West 2nd Road, Lingang New District, Pudong New Area (Shanghai) pilot Free Trade Zone, Shanghai Patentee after: Shanghai Shidao intelligent Pharmaceutical Technology Co.,Ltd. Address before: 201102 room d1006, 1f, No. 258, Pingyang Road, Minhang District, Shanghai Patentee before: SHANGHAI TCMCARES TECHNOLOGY Co.,Ltd. |